Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease: Two indications for photopheresis in dermatology

Dermatologic Clinics

Volumn 18, Issue 3, 2000, Pages 417-423

  Girardi, Michael ^b   Heald, Peter W ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; COMORBIDITY; ELECTRON BEAM; GRAFT VERSUS HOST REACTION; HUMAN; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; REVIEW; SKIN LYMPHOMA; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA; TREATMENT INDICATION;

EID: 0033875209     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70190-X     Document Type: Article

References (31)

1. Photopheresis for the treatment of cutaneous T-cell lymphoma
2. Infections complicating mycosis fungoides and Sezary syndrome
3. Photopheresis for the treatment of cutaneous T-cell lymphoma
4. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)
5. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: Preliminary results
6. Successful management of the Sezary syndrome: Mobilization and removal of extravascular neoplastic T cells by leukapheresis
7. Specific suppression of lupus like graft versus host disease using extracorporeal photochemical attenuation of effector lymphocytes
8. Extracorporeal photochemotherapy in human and murine graft-versus-host disease
9. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease
10. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy
11. Profound deficiency in normal circulating T-cells in erythrodermic cutaneous T-cell lymphoma
12. Palliative and remittive effects of oral bexarotene therapy in the management of erythrodermic cutaneous T-cell lymphoma
13. Cutaneous T-cell lymphoma
14. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides
15. Etretinate as an effective adjunctive therapy for recalcitrant palmar/plantar hyperkeratosis in patients with erythrodermic cutaneous T-cell lymphoma undergoing photopheresis
16. Sezary syndrome: Treatment with a prednisolone chlorambucil combination
17. Successful treatment of chronic graft-versus-host disease with extracorporeal photophoresis
18. Inhibition of anti-skin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes
19. Septicemic complications of the cutaneous T-cell lymphomas
20. Oral etoposide in the treatment of cutaneous large-cell lymphomas
21. Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low dose interferon alfa therapy
22. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease
23. Acute and chronic graft versus host disease: Histopathological evidence for two distinct pathogenetic mechanisms
24. Toxic epidermal necrolysis and graft vs. host disease: A clinical spectrum but a diagnostic dilemma
25. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA identical siblings
26. Molecular staging of cutaneous T-cell lymphoma: Evidence for systemic involvement in early disease
27. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma
28. Systemic chemotherapy and extracorporeal photochemotherapy and T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy
29. Detection of early cutaneous T cell lymphoma
30. Low dose methotrexate for Sezary syndrome
31. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma